skip to main content

News Archive

Date: 11/12/2012
Scientists from UT Southwestern Medical Center and the University of Michigan Rogel Cancer Center have developed an innovative model for predicting the progression of skin cancer in patients.
Date: 10/30/2012
Written by Nicole Fawcett
Date: 10/17/2012
The University of Michigan Rogel Cancer Center is part of a national organization that has received $11.5 million to study sarcoma, a rare type of cancer that can occur in bones, muscle and fat.
Date: 09/25/2012
A new multi-million dollar program at the U-M Rogel Cancer Center will examine how patients make treatment decisions, how doctors make treatment recommendations and how to improve the process for better outcomes.
Date: 09/11/2012
Two different genetic mutations cooperate to induce adrenal cancer, according to a new study from researchers at the University of Michigan Rogel Cancer Center and University of Sao Paulo in Brazil.
Date: 08/30/2012
The Center for the Discovery of New Medicines (CDNM) will coordinate and support work in a range of departments and schools to streamline drug discovery and development, support the translation of early research toward patient use -- a gray area where funding is scarce -- and fully leverage the technical capabilities and intellectual resources at U-M in service of discovering the therapies of tomorrow.
Date: 08/28/2012
MidMichigan Health and the University of Michigan Health System have announced plans to affiliate as clinical and business partners, allowing for a collaboration on the development of a major regional cancer center treating the vast array of cancer diagnoses.
Date: 08/25/2012
The American Cancer Society Cancer Action Network (ACS CAN), the American Cancer Society Great Lakes Division and the University of Michigan Rogel Cancer Center (UMCCC) briefed members of Michigan's congressional delegation today in Ann Arbor to encourage sustained federal funding for cancer research.

Pages